London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So I posted a Morningstar snapshot in mid June showing polar cap with 5m shares, it is now over 7m shares, which seem to have come from Acccia.
The other ii are interesting and I will try report back next week on what is going on.
It’s getting exciting now. If RM does have the results, there are at least a few of reasons, that I can think of, he might hold on to them. a)They are crap, b) they are good and he wants them as insurance for the hospital trial results, c) allow an interested party to take a position (gran/pharma), d) Get the ducks lined up before all hell breaks loose. I don’t think he would hold on to them personally unless it involved a deal for SNG001, even then it would be a bit wrong morally given the current climate. He probably just doesn’t have them yet.
Or question rather.
Ghia - Yes...I realise this....but my point where was do MorningStar get their data ;)
Rich - As I mentioned earlier It was pointed out to me that there is a Morningstar pro subscription. It’s like £10k a year or similar and is used by fund managers and the like as a source of data. I think as a company Morningstar is a highly reputable source of data and some of it trickles out into the consumer facing web pages.
187,000 at 41.75 blows JBER away :)
Boom that’s unlocked it :)
Bella - eh?
The SP is exactly where it has been capped for ages and clearly Acacia (or Miton) are still selling (and have been since the date on those last TR-1s).
Ghia - I think some of it is old data. The entries all seem to have a last update date on the end. So I'd go with that for the most recent indication. Not sure where morningstar get the data for these people below the notifiable threshold.
10 June was a 10.32m day and 1 July was a 7.65m day so if we get any more large trading days then that should be clearest indication Acacia are dumping again...
The SP has now been released until next block sold...
I suspect its simply a case of up front selling Acacia shares by one or more brokers who know they can buy them from Acacia within an agreed price range. It's a form of rince and repeat...
Rich - The morning star data is a bit confusing because if you toggle between Funds and Institutions and Buying Selling and Major you get different numbers for the Miton holding.
I'd love to know the story behind Polar Capital above 5% but no TR1?
Percentage
holding of
Ordinary fully diluted
Director Total options shares Total interest share capital
Richard Marsden 3,533,839 367,825 3,901,664 2.44%
-------------- ---------- --------------- ---------------
Dr. Phillip Monk 1,948,582 244,600 2,193,182 1.37%
-------------- ---------- --------------- ---------------
John Ward 2,481,064 367,577 2,848,641 1.78%
-------------- ---------- --------------- ---------------
Simon Shaw - 1,531,239 1,531,239 0.96%
-------------- ---------- --------------- ---------------
Iain Buchanan 212,765 112,741 325,506 0.20%
-------------- ---------- --------------- ---------------
Dr. Bruce Campbell - 322,830 322,830 0.20%
-------------- ---------- --------------- ---------------
Prof. Stephen Holgate - 886,931 886,931 0.56%
-------------- ---------- --------------- ---------------
Sorry that was 2.4% of company!
As I just posted elsewhere, the MorningStar link someone provided has helped fill in the remaining pieces of puzzle to me and I think it's quite simple actually. I thought Acacia would be down a little more.....however that link shows it wasn't just Acacia selling. It was Miton too.
So I think all the order book games are easy to explain now. We had Acacia doing most of the selling but Miton have been selling too. So two competing sellers.
We can also see a fund (Chelverton) increasing in the past (and I suspect there's been another one recently, especially on the day of highly aggressing buying into the sell order capping the price). Maybe it's them raising their position or someone else.
So we've simply seen the price capped by two sellers and at certain points in time another II buyer takes lumps out of them (along with PIs). Miton only have 1.6m left as of four days ago according to MorningStar. Acacia probably have 9/10/11m left.
Shouldn't be too much longer before the brakes of these two finally come off.
Acacia are American, so if they were still shareholders they should be on list at Morningstar!
What qualifies you to know how long the results would take?
gkb.....2.9% is total holding of directors.
MIggy ,
It normally takes 3-5 weeks max max to get results
RIchard has the results
Who’s timescale? I believe they were permitted to be unblinded so as to support Covid data. So why wouldn’t it be released with the Covid results. I suspect the company knows home trial data will be far superior to hospital data so maybe COPD will be released to soften any blow should it roll that way. Early use, in the home is where this drug will be most effective. I don’t think people should get too carried away with hospital data tbh.
MIggy,
Goes against all logic and timescales if he has'nt got them
Maybe because he doesn’t have them yet!
RIchard indeed seems a decent bloke but that's what worries me ...
Why has'nt he published the COPD results ?
Fecks sake (version = versus).
Also shows Miton reducing (1.6m left as of 30th Jun). So there's probably been games between new buying versions Acacia flipping and one fund reducing. That's been the backdrop and all should be done soon :)
Can’t remember if RM holds 2.9% or 2.9million shares either way its quite a lot so he shouldn’t lack for motivation.:)
I think RM is as steady as a rock of granite tbh. Whenever interviewed he is always engaging and honest to answer. Couple of times he has stated he cannot answer because of market regs but no problem with that. He’s been at Synairgen for years started as a general manager so knows the company and product inside out. He’s had the decency to respond to a few PI’s on here myself included and that’s whilst conducting trials, clearly he didn’t need to do that so for my money he’s a decent bloke. Doesn’t mean the drug will work of course but if he believes in it then it’s good enough for me.